Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Celltrion
Incheon, South Korea
A
501-1000 Employees
2002
Key takeaway
Celltrion is a global biopharmaceutical company that provides comprehensive solutions throughout the biopharmaceutical process, including R&D and clinical trials. It has a strong focus on innovative biologics and has submitted a Biologics License Application (BLA) to the U.S.
Reference
Product
Technology
Femtobiomed
Seongnam-si, South Korea
A
11-50 Employees
2011
Key takeaway
FEMTOBIOMED.inc is focused on advancing targeted gene delivery through innovative multiplexed cell therapeutics.
Reference
Core business
FEMTOBIOMED
BIORCHESTRA
Chungju-si, South Korea
A
1-10 Employees
2016
Key takeaway
BIORCHESTRA focuses on developing innovative RNA medicines and delivery systems addressing unmet medical needs, particularly in neurodegenerative and rare diseases of the Central Nervous System. Their best-in-class technology enhances the targeted delivery of RNA therapeutics, which may relate to advancements in bispecific antibody approaches.
Reference
Core business
BIORCHESTRA – Innovative RNA Therapeutics
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Onegene Biotechnology
Seongnam-si, South Korea
A
- Employees
2016
Key takeaway
Onegene Biotechnology is focused on advancing multi-target drug development, which includes their flagship program, OGB21502, a tetraspecific drug for NASH treatment. They are also developing trispecific drugs for conditions like IPF and immuno-oncology, highlighting their expertise in creating innovative multi-specific mechanisms.
Reference
Core business
ONEGENE BIOTECHNOLOGY
MxT Biotech
Seoul, South Korea
A
1-10 Employees
2021
Key takeaway
The company highlights its innovative Hydroporator® technology, which enhances the delivery of various therapeutic agents, including proteins, into primary cells. This platform is pivotal in advancing cancer immunotherapy and cellular engineering.
Reference
Core business
MxT Biotech :: Microfluidics x Therapy
We transform cancer immunotherapy, cellular engineering and genome editing with our patented non-viral genome editing technology, Hydroporator .
MediHeroes
Seoul, South Korea
A
1-10 Employees
2020
Key takeaway
MediHeroes is an international B2B medical marketplace that connects quality medical supplies and service providers with buyers, addressing concerns about product verification and seller trustworthiness.
Reference
Core business
B2B Medical Platform | MediHeroes | MedicalDevice
COVID-19 test kits | MediHeroes is an international B2B medical marketplace for quality MedicalDevices.
Genuv
Seoul, South Korea
A
11-50 Employees
2016
Key takeaway
Genuv is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases by stimulating neural stem cells and restoring central nervous system (CNS) function. They emphasize innovative approaches to drug discovery, including generating optimal antibodies against challenging targets and targeting immune cells to normalize the immune response in specific diseases.
Reference
Core business
Genuv
Biopharmaceutical company. 신약발굴 플랫폼 기술을 바탕으로 퇴행성 뇌질환, 면역질환, 암질환 등, 난치성 질환분야에서 치료제를 개발하는 연구 중심 신약 개발 기업.
GENECAST
Seoul, South Korea
A
11-50 Employees
2016
Key takeaway
GENECAST is a company that specializes in ctDNA liquid biopsy, focusing on improving cancer management through enhanced detection sensitivity. Their innovative ADPS™ technology allows for early cancer diagnosis, which could potentially lead to more effective treatment options and higher success rates in targeted therapy development.
Reference
Core business
Liquid Biopsy for Cancer Diagnosis - GENECAST
GENECAST specializes in Liquid Biopsy for early detection in Cancer Diagnosis. We have developed ADPS™, a Technology with 0.001% sensitivity ✓ Contact Us.
Clecell co.ltd
Seongnam-si, South Korea
A
11-50 Employees
2016
Key takeaway
The company is innovating in the field of personalized and regenerative medicine through its advanced bioprinting and tissue engineering technologies, which enable the creation of realistic 3D cancer tissues and organoids for efficient testing of chemotherapeutic agents.
Reference
Core business
CLECELL | Biotechnology company | South Korea
CLECELL is trailblazing the field of personalized and regenerative medicine with our revolutionary bioprinting and tissue engineering technology.
Sartorius Korea Biotech
Seongnam-si, South Korea
A
51-100 Employees
2005
Key takeaway
Sartorius is a specialized company in bioprocessing that provides integrated foundational technologies to support biopharmaceutical companies in the safe, rapid, and cost-effective development and production of biopharmaceuticals, including therapeutic antibodies and biosimilars.
Reference
Core business
싸토리우스 코리아
싸토리우스는 바이오/제약산업의 연구개발/생산설비를 위한 첨단장비와 서비스를 제공하며, 안전하고 경제적으로 생산/개발할 수 있는 솔루션을 제공합니다
Technologies which have been searched by others and may be interesting for you:
The Bispecific Antibody industry in South Korea is burgeoning, driven by advancements in biopharmaceutical research and development. A key consideration for potential entrants or investors is the regulatory landscape, which includes compliance with the Ministry of Food and Drug Safety (MFDS) guidelines. These regulations ensure that products meet safety and efficacy standards, which can be a lengthy process. Challenges such as high research and development costs, as well as the complexity of manufacturing bispecific antibodies, can pose significant hurdles. However, opportunities abound due to a growing demand for innovative cancer therapies and the establishment of research collaborations between academia and industry. South Korea's competitive landscape features both established biopharma companies and emerging startups, fostering a dynamic environment for innovation. The global market relevance is also notable, as South Korean firms are increasingly participating in international partnerships and clinical trials, positioning themselves as key players in the global bispecific antibody market. Environmental considerations are becoming more significant, with companies being urged to adopt sustainable practices in their manufacturing processes. Overall, a comprehensive understanding of these factors is essential for anyone looking to navigate the bispecific antibody sector in South Korea effectively.
Some interesting numbers and facts about your company results for Bispecific Antibody
| Country with most fitting companies | South Korea |
| Amount of fitting manufacturers | 14 |
| Amount of suitable service providers | 7 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2002 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Bispecific Antibody
What are related technologies to Bispecific Antibody?
Based on our calculations related technologies to Bispecific Antibody are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Bispecific Antibody?
Start-Ups who are working in Bispecific Antibody are MxT Biotech
Which industries are mostly working on Bispecific Antibody?
The most represented industries which are working in Bispecific Antibody are Biotechnology, Other, Medical
How does ensun find these Bispecific Antibody Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.